Evidence map›Paper›PMID 19747859›Full record

ArticleImmunity2009

Small, mobile FcepsilonRI receptor aggregates are signaling competent.

Nicholas L Andrews, Janet R Pfeiffer, A Marina Martinez, David M Haaland, Ryan W Davis, Toshiaki Kawakami, Janet M Oliver, Bridget S Wilson, Diane S Lidke

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Desensitization for the prevention of drug hypersensitivity reactions.The Korean journal of internal medicine · 2022
    Review
  14. Article
  15. Regulation of myeloid-cell activation.Current opinion in immunology · 2021
    Review
  16. Lipid-based and protein-based interactions synergize transmembrane signaling stimulated by antigen clustering of IgE receptors.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Nicholas L AndrewsDepartment of Pathology and Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM 87131, USA.
Janet R Pfeiffer
A Marina Martinez
David M Haaland
Ryan W Davis
Toshiaki Kawakami
Janet M Oliver
Bridget S Wilson
Diane S Lidke
New Mexico Cancer Center · USUniversity of New Mexico · USSandia National Laboratories California · USLa Jolla Institute for Immunology · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM TRAININGP50GM085273 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI EDWARDS, JEREMY S · 2009 to 2018
$26.1M
Mapping for Specialized Domains for FCeRI Signaling & InternalizationR01AI051575 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WILSON, BRIDGET S · 2003 to 2013
$3.3M
Signaling Activity of lgE Receptor SubunitsR01GM049814 · NIGMS · UNIVERSITY OF NEW MEXICO · PI OLIVER, JANET M. · 1993 to 2008
$2.6M
TOPOGRAPHICAL MODELING OF FCRI /FPR SIGNALING PATHWAYSP20GM067594 · NIGMS · UNIVERSITY OF NEW MEXICO · PI OLIVER, JANET M · 2002 to 2007
$1.6M
META DETECTOR &405 NM LASER: TUBERCULOSIS, PSEUDOMONAS IN CF REGULATION OF MUCOS10RR019287 · NCRR · UNIVERSITY OF NEW MEXICO · PI WANDINGER-NESS, ANGELA · 2004 to 2004
$363k
A CONFOCAL MICROSCOPE FOR HEALTH SCIENCES RESEARCHS10RR014668 · NCRR · UNIVERSITY OF NEW MEXICO · PI WANDINGER-NESS, ANGELA · 2000 to 2000
$300k
Zeiss Axiovert 2000 for Live Cell ImagingS10RR016918 · NCRR · UNIVERSITY OF NEW MEXICO · PI WANDINGER-NESS, ANGELA · 2002 to 2002
$135k
HIGH RESOLUTION DIGITAL CAMERA FOR TEM: POLYCYSTIC KIDNEY DISEASES10RR022493 · NCRR · UNIVERSITY OF NEW MEXICO · PI WILSON, BRIDGET S · 2006 to 2006
$92k
ENHANCING MULTIDISCIPLINARY BIOMEDICAL RESEARCHP20RR011830 · NCRR · UNIVERSITY OF NEW MEXICO · PI EATON, R P · 1996 to 1998
–
NCI NIH HHS P30 CA118100NCRR NIH HHS P20 RR11830NCRR NIH HHS RR022493NCRR NIH HHS S10 RR016918NCRR NIH HHS S10 RR019287NCRR NIH HHS S10 RR022493NCRR NIH HHS S10 RR14668NCRR NIH HHS S10 RR19287NIAID NIH HHS R01 AI051575NIGMS NIH HHS GM067594NIGMS NIH HHS P20 GM067594NIGMS NIH HHS P20 GM67594NIGMS NIH HHS P50 GM085273NIGMS NIH HHS R01 GM049814NIGMS NIH HHS R01 GM49814PHS HHS S10 RRI5734
6 · The paper itself

Abstract

Crosslinking of IgE-bound FcepsilonRI triggers mast cell degranulation. Previous fluorescence recovery after photobleaching (FRAP) and phosphorescent anisotropy studies suggested that FcepsilonRI must immobilize to signal. Here, single quantum dot (QD) tracking and hyperspectral microscopy methods were used for defining the relationship between receptor mobility and signaling. QD-IgE-FcepsilonRI aggregates of at least three receptors remained highly mobile over extended times at low concentrations of antigen that induced Syk kinase activation and near-maximal secretion. Multivalent antigen, presented as DNP-QD, also remained mobile at low doses that supported secretion. FcepsilonRI immobilization was marked at intermediate and high antigen concentrations, correlating with increases in cluster size and rates of receptor internalization. The kinase inhibitor PP2 blocked secretion without affecting immobilization or internalization. We propose that immobility is a feature of highly crosslinked immunoreceptor aggregates and a trigger for receptor internalization, but is not required for tyrosine kinase activation leading to secretion.

Indexed as

Protein MultimerizationSignal TransductionAnimalsAntigensCell Line, TumorImmunoglobulin EIntracellular Signaling Peptides and ProteinsPhosphorylationProtein SubunitsProtein TransportProtein-Tyrosine KinasesQuantum DotsRatsReceptors, IgESyk KinaseAntigensImmunoglobulin EIntracellular Signaling Peptides and ProteinsProtein SubunitsProtein-Tyrosine KinasesReceptors, IgESyk KinaseSyk protein, rat

Identifiers

PMID19747859
PMCPMC2828771
OpenAlexW1969112250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.